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ABSTRACT ERCC4 was previously identied in somatic
cell hybrids as a human gene that corets the nucleotide-
excision-repair deficiency in mutant hamster cells. The cloning
strategy for ERCC4 involved transfection of the repair-
deficient hamstr cell line UV41 with a human sCos-1 cosmid
library derived from chromosome 16. Enhanced UV resistance
was seen with one cosmid-library transformant and two sec-
ondary transformants of UV41. Cosmid clones carrying a
fimetional ERCC4 gene were isolated from a library of a
secondary transformant by sing in Escherichia cofl for
expression of a linked neomycin-resistance gene that was
present in the sCos-1 vector. The cosmids mapped to 16pl3.13-
p13.2, the location to ERCC4 by using somatic cell
hybrids. Upon trnfection into UV41, six cosmid clones gave
partial correction ranging from 30% to 64%, although all
appeared to contain the complete gene. The capacity for in vitro
excision ofthymie dimers ftom a plasid bytornt cell
extacts correlated qualitatively with enhanced UV resistance.
Nucleotide-excision repair is a major pathway that removes
UV-radiation photoproducts, bulky monoadducts, cross-
links, and oxidative damage from DNA by incising the
damaged strand on both sides of the lesion (1-3). Seven
human genes in this pathway have been identified and cloned
by using mutants developed in rodent cells or derived from
humans having the disorder xeroderma pigmentosum (XP)
(4). Studies ofhamster and mouse mutant lines first identified
five genetic complementation groups (5, 6) having extreme
UV-radiation sensitivity and excision-repair deficiency.
From these groups of mutants, the complementing human
genes ERCCI (7), XPD/ERCC2 (8), XPB/ERCC3 (9), and
XPG/ERCCS (10) were cloned and shown to substantially
overlap (9, 11-13) with the seven excision-deficient groups of
XP (14). The mutants in rodent complementation groups 6-11
have lesser degrees of UV sensitivity than groups 1-5 (15-
17), and of the former set, only the gene correcting group 6,
CSB/ERCC6, has been isolated (18). By complementing XP
cells, the XPA (19) andXPC (20) genes were isolated-genes
so far not represented among the rodent groups.
Nucleotide-excision-repair complementation group 4 is
represented by mutants UV41 (5) and UV47 (21), both of
which are highly UV-sensitive (n6-fold) and extremely sen-
sitive to mitomycin C ("'100-fold) and other DNA cross-
linking agents (21). These mutants and those in group 1, such
as UV20 (5), are so far unique in their extreme sensitivities
to both UV-radiation and cross-linking agents. These prop-
erties suggest that the complementing ERCCI and ERCC4
genes are involved in distinct but overlapping pathways of
monoadduct and cross-link removal. Previous transfection
studies using human genomic DNA resulted in corrected
UV41 transformants without cloning ofthe ERCC4 gene (22).
Since ERCC4 was assigned to chromosome 16 (23) and a
cosmid library of this chromosome was available, we chose
a cloning strategy in which UV41 was first corrected by
transfection with that library. We report here the isolation of
functional cosmid clones that map to the previously assigned
chromosomal region of ERCC4 (16p13.13-p13.2) and par-
tially restore UV-resistance.
MATERIALS AND METHODS
Cels and Culture Conditions. Mutant UV41 (5) and its
transformants were grown in either monolayer or suspension
culture in minimum essential medium, a modification, sup-
plemented with 10o (vol/vol) fetal bovine serum and anti-
biotics as reported (8). Colony-forming ability of transform-
ants was determined after exposure to UV-radiation as
reported (5). Triplicate 10-cm dishes were used for each dose
point.
Cosmid and Genomic DNA Transfections. A chromosome
16 cosmid library in the vector sCos-1 (24) was kindly
provided by Larry Deaven (Los Alamos National Laborato-
ry). Cosmid DNA was introduced into UV41 cells by elec-
troporation ofthree aliquots of5 x 106 cells; each aliquot was
mixed with 5 pg ofDNA in a 1-ml cuvette of a GIBCO/BRL
Cell Porator (300 V, 1600 tF). Cells were plated at 5 x 10W
cells per 10-cm dish and allowed 48 h for expression. Mito-
mycinC to 10nM and Geneticin to 1.7 mg/ml were added and
incubation was continued for 10 days. One primary trans-
formant (H41T1) was recovered, expanded in medium con-
taining Geneticin, and shown to be cross-resistant to UV-
radiation at 5 J/m2.
For the secondary transfection, high molecular weight
(=200 kb) DNA from 1.1 x 109 cells of the primary trans-
formant grown in suspension culture was prepared (25). DNA
in solution was concentrated -5-fold by repeated extractions
with 1-butanol, followed by dialysis against 0.01 M Tris HCI/
0.001 M Na2EDTA, pH 8.0. Calcium phosphate precipitates
were prepared in 2 ml (26), and 20 pg of DNA in 1 ml was
added per dish to 28 10-cm dishes, each containing 2 x 106
cells and 10 ml of medium. After 22 h, the dishes were rinsed
and refed with 20 ml offresh medium. Afteran additional 29-h
expression, dishes were UV-irradiated at 3.5 J/m2 and refed
with 20 ml of medium containing Geneticin.
To test for correction of UV41 by cosmid clones, DNA
samples were introduced into UV41 as calcium phosphate
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precipitates (5 pg of DNA per dish) or by electroporation
(0.5-5 pg per cuvette). After a 24-h expression, cells were
exposed to UV-radiation at 3.5 J/m2 and incubated =8 days
in medium containing Geneticin. Colonies were isolated
using Pipetman tips and checked for stable UV-resistance.
Cosmid Library Construction and Cloning. High molecular
weight DNA from 2 x 108 cells of secondary transformant
H41T2-1 was prepared as described for the primary trans-
formant. Genomic DNA was sheared by aspirating twice in a
Pipetman 1000 tip to produce a homogeneous solution and was
partially digested with restriction endonuclease Sau3AI to
convert %30% of the DNA to 30-50 kb. Genomic DNA was
ligated to vector pl4B1 (8) at the unique BamHI site using a
vector/insert ratio of 32:1 at 0.22 pg/pl. Ligation products
were packaged with Gigapack II Gold extracts (Stratagene),
and the resulting cosmids were transfected into Escherichia
coli DH5aMCR (GIBCO/BRL). After infection, cells were
concentrated and plated onto agar dishes with Luria-Bertani
medium containing kanamycin at 50 pg/ml. Cosmid DNAs
from kanamycin-resistant clones were purified using
QIAwell-8 and plasmid purification kits (Qiagen, Chatsworth,
CA).
Southern Blot ofERCC4 Cosmids. Cosmid DNAs (see Fig.
6) were digested with &coR and size-fractionated on 1.0%o
agarose at 75 ng ofDNA per lane. Two cDNA clones, cER44
and cER4-5 (L.H.T. and K.W.B., unpublished results), were
digested with Xba I, which separates insert from vector, and
were present in the gel at 25 ng per lane. A 19-nt oligomer,
derived from sequence immediately upstream of the polya-
denylylation signal of cDNA clone cER4-4 and not found in
cER4-5, was used as probe. DNA was transferred to nylon
membranes (GeneScreenPlus; DuPont/NEN) and hybrid-
ized with 80 ng of 32P-end-labeled probe (specific activity, 1.4
x 109 cpm/pg) in 1 M NaCl/10% (wt/vol) dextran sulfate/
1.0o SDS/sonicated herring sperm DNA (0.1 mg/ml) for 3 h
at 42C. The membrane was then rinsed with 2x SSC at room
temperature for 15 min and 6x SSC at 420C for 2 min (1x SSC
is 0.15 M NaCl/0.015 M sodium citrate, pH 7.0).
In Vitro Assay of Excision Repair. Cell extracts were
prepared as described (27), dialyzed overnight against stor-
age buffer [25 mM Hepes, pH 7.9/100 mM KCI/12 mM
MgCl2/0.5 mM EDTA/2 mM dithiothreitol/17% (wt/vol)
glycerol], and stored in small aliquots at -80°C. The plasmid
DNA substrate (pUNC19914) is a semisynthetic covalently
closed plasmid containing four thymine dimers at unique
sites. It was prepared with 32p label at the 11th phosphodi-
ester bond 5' to each thymine dimer as described (28). We
used >2 x 10W cpm per reaction mixture (-0.6 pg). The
plasmid and a total of 150 ,g of extract were incubated for 2
h at 30°C in 60-rd reaction mixtures, and the reaction prod-
ucts were analyzed as described (28).
In two of the experiments, recovered cpm were determined
by Cerenkov counting and equal cpm were loaded on the gel.
Quantitation was by scanning the region of the gel containing
the excision products by using a Zeineh soft laser scanning
densitometer. For the third experiment, loaded cpm were
normalized after scanning of the dried gel with a Fuji
BAS1000 Bio-Imaging Analyzer.
RESULTS
Production of Primary and Secondary Transformants of
UV41 Cells. The procedure used to clone ERCC4 is outlined
in Fig. 1. Transfection of 107 UV41 cells by electroporation
with the sCos-1 library of human chromosome 16 resulted in
one primary transformant that was resistant to both Geneticin
and 10 nM mitomycin C, a concentration that is nontoxic to
wild-type AA8 cells. This clone (H41T1) was shown to be
cross-resistant to UV-radiation, implying that it was a gen-
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FIG. 1. Strategy for cloning ERCC4 by using a chromosome 16
cosmid library.
cin C metabolism (29). DNA isolated from H41T1 cells was
used in a secondary transfection that employed calcium
phosphate precipitates to maximize the amount of DNA
transferred. Two transformants resistant to both Geneticin
and UV-radiation were obtained from 5.6 x 107 cells. All
three transformants were analyzed on a Southern blot by
using as the probe an ApaLI fragment of sCos-1 that spanned
a 1.25-kb region starting just upstream of the origin of
replication and extending into the ampicillin-resistance gene
(results not shown). The findings suggested that (i) the
ERCC4 circular sCos-1 cosmid had broken near the orgin of
replication when integrating into the primary transformant
and (ii) the primary transformant contained two copies of
sCos-1 while the secondary transformants contained one
copy.
Cosmid Cloning of ERCC4 by Linkage to the Neomycin-
Resitane (neo) Gene. DNA from secondary transformant
clone H41T2-1 was used to construct a cosmid library with
the pl4B1 vector, which contains no neo gene (8). Cosmids
were transfected into E. coli, and a selection for kanamycin
resistance (conferred by the neo gene of sCos-1 present in the
insert) was performed to rescue ERCC4 sequences (see Fig.
1). Thirty cosmid clones were recovered from 2.4 x 106
transfected bacteria, and six clones were capable of confer-
ring UV resistance when introduced into UV41 cells by
electroporation. The six functional cosmids (pER4-2, -3, 4,
-5, -6, and -7) contained six common EcoRP restriction
fiagments ranging from 0.7 to 7.5 kb, and three of these
fragments were common to six nonfunctional cosmids. For
each functional cosmid, one or more UV41 transformant
clones that survived UV-irradiation 24 h after transfection
were isolated for further analysis.
Chromosomal Mapping of Functonal Cosnid Clones. To
test whether the recovered cosmids contained the ERCC4
gene as defined by localization to chromosome 16pl3.13-
p13.2 in cell hybrids (23), several functional cosmid clones
were mapped to human metaphase chromosomes by fluores-
cence in situ hybridization. These cosmids specifically hy-
bridized to the predicted region, as shown for cosmid pER4-2
in Fig. 2. Because ofthe linkage of this chromosome 16 insert
--F..E.RCC.4
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FIG. 2. Localization of
ERCC4 cosmid clones on two nor-
mal human metaphases (Aand B)
by fluorescence in situ hybridiza-
tion. Cosmid clone pER4-2 was
biotinylated and hybridized to hu-
man metaphase prepaations as
described (23). The arrows mark
the position of the centromere of
chromosome 16. Hybridization is
telomeric of the midpoint of the p
arm (it appears to be at the end of
the p arm of the chromosome on
the left inA because the end ofthe
p arm is folded back).
sequence to the neo gene, we must have cloned a human
sequence rather than a reverted hamster ERCC4 gene.
Restoration ofUV Ressnce in Transformants. To evaluate
the level of correction obtained in the transformants, UV-
radiation survival curves were obtained as shown in Fig. 3.
All transformants except one (clone HER4.5.1) conferred
UV-resistance. This clone probably survived the initial
screening because of transient correction by the cosmid
DNA. For all other transformants, two aspects of the cor-










FIG. 3. UV-radiation survival curves of cosmid transformants of
UV41. e/dashed and dotted lines, UV41, two experiments; A/
dashed line, wild-type AA8; (/dotted line, primary transformant
H41T1; o, secondary transformant H41T2-1; t/solid line, HER4.2.3;
A/dotted line, HER4.3.3; C/dashed line, HER4.4.2; C/solid line,
HER4.4.3; */solid line, HER4.5.1; x/solid line, HER4.5.2;
x/dashed line, HER4.5.3; x/dotted line, HER4.5.4; +, HER4.6.3;
*/dotted line, HER4.7.1; */dashed line, HER4.7.3.
resistance was incomplete and ranged from 30% to 64% based
on D37 (the fluence that reduces survival to 37%). Many ofthe
transformants derived with cosmid clones had significantly
higher survival than either the primary or secondary trans-
formant. Thus, if the complete gene is present in the trans-
formants, then it appears that human ERCC4 does not fully
correct the hamster-cell mutation. (ii) For the transformants
derived from the six cosmid clones, there was variability in
the level of correction, both among the transformants for a
given cosmid (e.g., transformants of cosmid pER4-5) and
among those of different cosmids. Two sources of such
variability could be the number of copies ofERCC4 and the
chromosomal site(s) of integration.
Restoration of Excinuclease Activity In Transfornants. The
enhanced UV-survival of the transformants implied partial
restoration of repair. Increased UV-survival could be caused
by transfection with genes involved in cell cycle regulation
(30). We wished to confirm the restoration of excision
activity by using an assay specific for excision. Thus, we
measured the repair capacity of several transformants with
the recently developed excinuclease assay in which excised
thymine dimers are detected in radiolabeled oligonucleotides
that are 27-29 nt long (28). Fig. 4 shows an autoradiogram
comparing transformants and parental cell lines. Human
HeLa cells had more activity than CHO AA8 cells, whereas
the UV41 mutant had no detectable activity. Intermediate
levels of repair were seen with the secondary transformant
H41T2-1 and the cosmid transformants HER4.4.2 and
HER4.7.3. Very efficient complementation was seen in
mixed extracts of UV41 and the group 5 mutant UV135,
indicating that UV41 extract can be fully complemented. The
repair levels of the cell lines shown in Fig. 4 are summarized
in quantitative form in Fig. 5. The relative levels of repair of
wild-type AA8 and the three transformants were in the same
order as the levels of cellular resistance measured by survival
curves (e.g., D37 values). The D37 values taken from Fig. 3 are
as follows: AA8, 11.6 J/m2; HER4.7.3, 7.9 J/m2, HER4.4.2,
6.3 J/m2, and H41T2-1, 4.5 J/m2. Thus there is a qualitative
correlation between repair measured in vitro and cell survival
after UV-irradiation.
Presence of 3'-End Sequence in FunctionalERCC4 Cosmids.
Incomplete correction might be due to having an incomplete
gene in the original sCos-1 library; either end could be
truncated. However, if the 5' end were deleted, one would
expect extremely low transfection efficiencies with the
cosmid clones (see Discussion). Since truncation ofthe 3' end
of ERCC4 was a more likely possibility, we tested the
cosmids by using an oligonucleotide probe for a noncoding
Genetics: Thompson et al.
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FIG. 4. Autoradiogram of ex-
cision products in the excinu-
clease assay. Lanes: 1, size mark-
_29 ers; 2-4, control cell lines; 5, sec-
\28 ondary transformant; 6 and 7,
27 cosmid transformants of differing
UV sensitivity; 8, UV41 extract
combined with extract from
UV135 showing efficient correc-
tion of the repair deficiency. The
positions of the main excision
products (27-29 nt) are indicated.
region just upstream of the polyadenylylation site in one
cDNA clone. As shown in Fig. 6 (lanes 8-13), all six cosmids
that restored UV-resistance were clearly positive for a 4.8-kb
EcoRI fiagment. At the same time, six cosmids that did not
conferUV resistance were all negative (lanes 2-7). The probe
also detected a cDNA clone containing its complementary
sequence (lane 1, arrow) but gave a weak signal with acDNA
clone that lacked this sequence (lane 14). The faint bands
seen for some nonfunctional cosmids (lanes 2, 4, 5, and 7)
appear to be due to nonspecific hybridization. These results
argue strongly that the 3' end of ERCC4 is present in the
functional cosmids and support our interpretation that the
incomplete correction we observe (Figs. 3-5) is most likely
not due to an incomplete gene.
DISCUSSION
We have presented the cloning of the human ERCC4 gene,














FIG. 5. Quantitative level ofcorrection inERCC4 transformants.
Excision is expressed relative to UV41 + UV135 complementation
(bar 4 x 5), which was present in all three experiments. For the data
set, n = 3 for H41T2-1, HER4.4.2, HER4.7.3, and UV41 + UV135
and n = 2 for AA8 and UV41. The value for UV41 was at background
(0.018) and was subtracted from the other values. Error bars are the
SEM.
FiG. 6. Test of cosmid clones for the presence df the 3' end of
ERCC4. An autoradiogram ofDNAs digested with EcoRI (cosmids)
orXba I (cDNAs, to release inserts of vector pEBS7) and hybridized
with a 32P-labeled oligonucleotide probe for the 3' end ofERCC4 is
shown. Lanes: 1, positive control (cDNA clone cER44); 2-7, six
nonfunctional cosmids (pER4-11, -12, -14, -16, -17, and -18, respec-
tively); 7-13, six functional cosmids (pER4-2, -3, -4, -5, -6, and -7,
respectively); 14, negative control (cDNA clone cER4-5).
series of genes that are required for the functioning of
nucleotide-excision repair in mammalian cells (5, 6). In a
previous study, transfection of CHO UV41 cells with human
DNA resulted in correction of cells to repair proficiency.
Cloning of the gene was hampered by the apparent absence
of repetitive sequences (22), which had been used to clone
other genes such as ERCC2 (8). We used the sCos-1 chro-
mosome 16-specific library for our initial transfection of
UV41 because the ERCC4 gene had been assigned to this
chromosome using CHO-human somatic cell hybrids (23).
The sequences that we cloned map to the expected region of
chromosome 16, confirming the previous chromosomal as-
signment.
From a technical standpoint, the ability of the neo gene of
sCos-1 to confer kanamycin resistance in E. coli eliminated
the need to perform hybridization screening of the cosmid
library prepared from the secondary transformant. The main
limitation of this approach for cloning other genes by trans-
fection/complementation is set by the size ofthe gene. Genes
up to =30 kb can be accommodated by cosmid vectors with
adequate efficiency. A survey of the sizes of known human
repair genes (4, 31-35) suggests that 5Oo of the genes
remaining to be cloned might be suitable for this approach as
cosmid libraries for most human chromosomes are available
in the National Gene Library Project.
The partial correction we observed with six cosmid clones
was as high as 64% based on survival ofUV41 transformants.
The CHO mutant UV140 (36), which has intermediate UV
sensitivity, was corrected to a similar maximum extent
(13-63%) by cosmid clone pER4-6 (L.H.T. and K.W.B.,
unpublished results). Transfection efficiencies for UV resis-
tance would be expected to be much lower than we observed
(1 X 10-4 for UV140 transfection) if the 5' end of the gene
were missing, requiring integration near a promoter. Se-
quence corresponding to the 3' end of the gene was present
in all six functional cosmids (Fig. 6). The incomplete correc-
tion we observed might result from inefficient gene expres-
sion, and the possibility remains that the cloned ERCC4
sequences are incomplete in the upstream region or rear-
ranged. Partial correction might also occur even if normal
ERCC4 protein levels are present in transformants. Several
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deficiency as efficiently as some other nucleotide-excision
repair genes such as ERCC2, which gave full correction of
UV5 cells (8), andXRCC1, which gave full correction ofEM9
cells (31). Studies using cell extracts to test for complemen-
tation suggest that both the ERCC1 and ERCC4 proteins, as
well as the XP-F and ERCC11 proteins (if indeed these
proteins are distinct from ERCC4), are present in a complex
(37-39). This complex may impose constraints on the effi-
ciency of complementation by a heterologous protein. The
human ERCC4 protein may not integrate well into the
hamster complex, particularly when an altered hamster pro-
tein is also present. The partial correction (=60%) also seen
with the intactERCCI gene present in a group 1 transformant
is consistent with this idea (40).
The variability among the UV-survival curves of the ge-
nomic and cosmid transformants (Fig. 3) suggests differences
in the repair capacity ofthe cells. Three of the cell lines were
examined in the recently introduced excinuclease assay,
which directly measures the removal of the major UV pho-
toproduct, thymine dimers, in the excised oligonucleotide.
These experiments confirmed that restoration of repair ca-
pacity had occurred in the transformants and that there was
a correlation between the levels of in vitro repair and relative
UV resistance.
Using the pER4-5 cosmid as probe, we have isolated
cDNA sequences that map to chromosome 16 (L.H.T.,
K.W.B., and M.J.S., unpublished results). Overexpressed
ERCC4 protein will now be needed to reconstitute the entire
nucleotide-excision-repair process in vitro.
We thank Dr. Larry Deaven for providing the sCos-1 library of
chromosome 16 and Catherine Buerchner for technical assistance
with the primary transfection. This work was done under the
auspices ofthe U.S. Department of Energy by Lawrence Livermore
National Laboratory under Contract W-7405-ENG-48, and the re-
search was funded partly by National Institutes of Health Grants
GM32833 and CA34936.
1. Friedberg, E. C. (1985) DNA Repair (Freeman, New York).
2. Sancar, A. & Tang, M. S. (1993) Photochem. Photobiol. 57,
905-921.
3. Satoh, M. S., Jones, C. J., Wood, R. D. & Lindahl, T. (1993)
Proc. Nati. Acad. Sci. USA 90, 6335-6339.
4. Hoeimakers, J. H. (1993) Trends Genet. 9, 211-217.
5. Thompson, L. H., Busch, D. B., Brookman, K. W., Mooney,
C. L. & Glaser, D. A. (1981) Proc. Natl. Acad. Sci. USA 78,
3734-3737.
6. Thompson, L. H. & Carrano, A. V. (1983) in Cellular Re-
sponses to DNA Damage, eds. Friedberg, E. C. & Bridges,
B. A. (Liss, New York), pp. 125-143.
7. van Duin, M., de Wit, J., Odijk, H., Westerveld, A., Yasui, A.,
Koken, M. H. M., Hoeijmakers, J. & Bootsma, D. (1986) Cell
44, 913-923.
8. Weber, C. A., Salazar, E. P., Stewart, S. A. & Thompson,
L. H. (1988) Mol. Cell. Biol. 8, 1137-1146.
9. Weeda, G., van Ham, R. C. A., Vermeulen, W., Bootsma, D.,
van der Eb, A. J. & Hoejmakers, J. H. J. (1990) Cell 62,
777-791.
10. Mudgett, J. S. & Macmnnes, M. A. (1990) Genomics 8, 623-
633.
11. Flejter, W. L., McDaniel, L. D., Johns, D., Friedberg, E. C. &
Schultz, R. A. (1992) Proc. Natl. Acad. Sci. USA 89, 261-265.
12. Scherly, D., Nouspikel, T., Corlet, J., Ucla, C., Bairoch, A. &
Clarkson, S. G. (1993) Nature (London) 363, 182-185.
13. O'Donovan, A. & Wood, R. D. (1993) Nature (London) 363,
185-188.
14. Vermeulen, W., Stefanini, M., Giliani, S., Hoejmakers,
J. H. J. & Bootsma, D. (1991) Mutat. Res. 255, 201-208.
15. Stefaini, M., Collins, A. R., Riboni, R., Klaude, M., Botta,
E., Mitchell, D. L. & Nuzzo, F. (1991) Cancer Res. 51,
3965-3971.
16. Riboni, R., Botta, E., Stefanini, M., Numata, M. & Yasui, A.
(1992) Cancer Res. 52, 6690-6691.
17. Thompson, L. H. (1989) Environ. Mol. Mutagen. 14, 264-281.
18. Troelstra, C., van Gool, A., De Wit, J., Vermeulen, W.,
Bootsma, D. & Hoejmakers, J. H. J. (1992) Cell 71, 939-953.
19. Tanaka, K., Satokata, I., Ogita, Z., Uchida, T. & Okada, Y.
(1989) Proc. Natd. Acad. Sci. USA 86, 5512-5516.
20. Legerski, R. & Peterson, C. (1992) Nature (London) 359,
70-73.
21. Hoy, C. A., Thompson, L. H., Mooney, C. L. & Salazar,
E. P. (1985) Cancer Res. 45, 1737-1743.
22. Duilhanty, A. M., Rubin, J. S. & Whitmore, G. F. (1988) Mu-
tat.;Res. 194, 207-217.
23. Liu, P., Siciliano, J., White, B., Legerksi, R., Callen, D.,
Reeders, S., Siciliano, M. J. & Thompson, L. H. (1992) Mu-
tagenesis 8, 199-205.
24. Evans, G. A., Lewis, K. & Rothenberg, B. E. (1989) Gene 7*,
9-20.
25. Sambrook, J., Fritsch, E. F. & Maniatis, T. (1989) Molecular
Cloning: A Laboratory Manual (Cold SpnDg Harbor Lab.
Press, Plainview, NY), 2nd Ed., pp. 9.16-9.19.
26. Corsaro, C. M. & Pearson, M. L. (1981) Somatic Cell Genet.
7, 603-616.
27. Manley, J. L., Fire, A., Cano, A., Sharp, P. A. & Gefter,
M. L. (1980) Proc. Natl. Acad. Sci. USA 77, 3855-3859.
28. Huang, J. C., Svoboda, D. L., Reardon, J. T. & Sancar, A.
(1992) Proc. Natl. Acad. Sci. USA 89, 3664-3668.
29. Dulhanty, A. M., Li, M. & Whitmore, G. F. (1989) CancerRes.
49, 117-122.
30. Teitz, T., Eli, D., Penner, M., Bakhanashvili, M., Naiman, T.,
Timme, T. L., Wood, C. M., Moses, R. E. & anaani, D.
(1990) Mutat. Res. 236, 85-97.
31. Thompson, L. H., Brookman, K. W., Jones, N. J., Allen,
S. A. & Carrano, A. V. (1990) Mol. Cell. Biol. 10, 6160-6171.
32. Robson, C. N., Hochhauser, D., Craig, R., Rack, K., Buckle,
V. J. & Hickson, I. D. (1992) Nucleic Acids Res. 20, 4417-
4421.
33. Noguiez, P., Barnes, D. E., Mohrenweiser, H. W. & Lindahl,
T. (1992) Nucleic Acids Res. 20, 3845-3850.
34. Nakatsu, Y., Hattori, K., Hayakawa, H., Shimizu, K. &
Sekiguchi, M. (1993) Mutat. Res. 293, 119-132.
35. Vickers, M. A., Vyas, P., Harris, P. C., Simmons, D. L. &
Higgs, D. R. (1993) Proc. Natd. Acad. Sci. USA 0, 3437-3441.
36. Busch, D., Greiner, C., Rosenfeld, K. L., Ford, R., de Wit, J.,
Hoeijmakers, J. H. J. & Thompson, L. H. (1994) Mutagenesis,
in press.
37. van Vuuren, A. J., Appeldoorn, E., Odjik, H., Yasui, A.,
Jaspers, N. G. J., Bootsma, D. & Hoeijmakers, J. H. J. (1993)
EMBO J. 12, 3693-3701.
38. Biggerstaff, M., Szymkowski, D. E. & Wood, R. D. (1993)
EMBO J. 12, 3685-3692.
39. Reardon, J. T., Thompson, L. H. & Sancar, A. (1994) Cold
Spring Harbor Symp. Quant. Biol. 58, 605-617.
40. Zdzienicka, M. Z., Roza, L., Westerveld, A., Bootsma, D. &
Simons, J. W. I. M. (1987) Mutat. Res. 183, 69-74.
Genetics: Thompson et al.
